Specifically, Notch3 inhibition enhanced the apoptotic effect of sorafenib in HCC cells via specific down-regulation of p21 and up-regulation of pGSK3βSer9 [108]. The gene discussed is NOTCH3; the disease is hepatocellular carcinoma.